Extracellular Matrix News Volume 3.11 | Mar 22 2012

    0
    99

    Extracellular Matrix News 3.11, March 22, 2012
         In this issue: Publications | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  Extracellular Matrix News on Twitter

    TOP STORY
    The Functional Properties of Nephronectin: An Adhesion Molecule for Cardiac Tissue Engineering
    Researchers investigated the suitability of the natural cardiac extracellular matrix component nephronectin as an adhesive material for cardiac tissue engineering. [Biomaterials] Abstract

    Webinar: Affordable, Defined hPSC Culture? Watch the video now.

    PUBLICATIONS (Ranked by Impact Factor of the Journal)

    Reconstitution of Laminin-111 Biological Activity Using Multiple Peptide Coupled to Chitosan Scaffolds
    The active peptide-chitosan matrices described here have potential for use as biomaterial for tissue engineering and regeneration. [Biomaterials] Abstract

    Biochemical and Mechanical Environment Cooperatively Regulate Skeletal Muscle Regeneration
    To directly determine how extracellular matrix and tissue stiffness combine to affect skeletal muscle fragmentation, migration, and fusion, researchers coated silicone-based substrates with matrices representative of transitional and differentiated environments. [FASEB J] Abstract

    The Host Response to Endotoxin Contaminated Dermal Matrix
    Researchers examined the in vitro and in vivo effects of endotoxin contamination within an extracellular matrix scaffold derived from porcine dermis upon the host immune response and the downstream ability of the scaffold material to promote constructive tissue remodeling. [Tissue Eng Part A] Abstract

    Development and Validation of a Three-Dimensional In Vitro Model for Uterine Leiomyoma and Patient-Matched Myometrium
    Researchers objective was to develop and validate a three-dimensional culture system of leiomyoma and myometrial cells. [Fertil Steril] Abstract

    Erythrocytes Express Chondroitin Sulphate/Dermatan Sulphate, Which Undergoes Quantitative Changes during Diabetes and Mediate Erythrocyte Adhesion to Extracellular Matrix Components
    Scientists explored the nature of glycosaminoglycans present in erythrocytes and its role on adhesion of erythrocytes from control and diabetic rats to major extracellular matrix components. [Biochimie] Abstract

    SPARC/SFN Interaction, Suppresses Type I Collagen in Dermal Fibroblasts
    Scientists determined that stratifin (SFN) and SPARC form a complex thereby controlling the type I collagen synthesis and expression in fibroblasts. The levels of these proteins in fibrotic tissues were also evaluated and a differential expression of these proteins between normal and fibrotic tissue confirmed their potential role in development of fibrotic condition. [J Cell Biochem] Abstract

    Beta3-Integrin Is Required for Differentiation in OC-2 Cells Derived from Mammalian Embryonic Inner Ear
    Researchers hypothesized that integrin proteins, which are involved in cell attachment to extracellular matrix proteins and cellular signaling, play a role in the differentiation process of the precursor inner ear epithelial cells. [BMC Cell Biol] Abstract

    Antibacterial Activity of Dentine and Pulp Extracellular Matrix Extracts
    Scientists’ aim was to determine whether extracellular matrix preparations from pulp and dentine possess antimicrobial activity. [Int Endod J] Abstract

    50,000 scientists receive our newsletters. Do your colleagues? Click to share this newsletter now.

    INDUSTRY NEWS

    MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
    MiMedx Group, Inc. announced the signing of a global distribution agreement with Systagenix, whereby Systagenix will co-market EpiFix®. [MiMedx Group, Inc.] Press Release

    Merck Partners with Academic Scientists and Biotechnology Entrepreneurs to Create the California Institute for Biomedical Research (Calibr)
    Merck announced a collaboration to create the Calibr, an independent, not-for-profit organization established to accelerate the translation of basic biomedical research into innovative, new medicines to treat disease. [Merck & Co., Inc.] Press Release

    POLICY NEWS

    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)
     
    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

    EVENTS

    NEW 4th International Symposium Interface Biology of Implant (IBI) 2012
    May 9-11, 2012
    Rostock, Germany

    NEW
    Canadian Connective Tissue Conference 2012
    June 8-10, 2012
    Toronto, Canada

    Visit our events page to see a complete list of events in the extracellular matrix community.

    JOB OPPORTUNITIES

    Scientist – hPSC Bioengineering (STEMCELL Technologies, Inc.)

    Scientist – Antibody and Hybridoma Technology Platforms (STEMCELL Technologies, Inc.)

    Business Analyst – Product Management (STEMSOFT Software, Inc.)

    Postdoctoral Fellow (Mount Sinai School of Medicine)

    PhD and Postdoctoral Positions (Leibniz Institute for Neurobiology) 

    Postdoctoral Fellow – Cell Biology (Institute for Systems Biology)


    Postdoctoral Fellow (Medical Research Council) 

    Postdoctoral Position (Thomas Jefferson University)


    Recruit Top Talent
    Reach more than 11,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

    Jobs are categorized regionally: United States, Canada, Europe, Middle East to Asia Pacific

    Visit here to post your career opportunities.

    Have we missed an important article or publication in Extracellular Matrix News? Click here to submit!

    Comments or Suggestions? Email info@connexoncreative.com with your feedback.

    Learn more about Extracellular Matrix Cell News: Archives | Events | Contact Us